Heart Failure Pharmacology
Sort by:
16th Annual Heart Failure Holiday Symposium
New Treatment Approaches to HFrEF: When to Use SGLT2, Vericiguat, Omecamtiv Mecarbil and IV Iron?
FEATURING
Mark Drazner
- 1,116 views
- February 18, 2021
- 12
ACC 2023 Conference Coverage
ACC 2023: Beyond the Guidelines - Emerging Pharmacologic Therapies for the Heart Failure Treatment
FEATURING
Freny Mody
- 1,868 views
- April 25, 2023
- 12
Mount Sinai Advanced Innovations in Heart Failure
Medical Therapy for Heart Failure in 2022
FEATURING
Anuradha Lala-Trindade
- 1,021 views
- March 2, 2022
- 11
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments
FEATURING
Rajeev C. Mohan
- 727 views
- June 13, 2023
- 10
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
Pillars of Therapy for Prevention of CVD in CKD Patients – the Cardiorenal Syndrome
FEATURING
Christian Mende
- 1,048 views
- November 27, 2023
- 12
Houston Shock Symposium
Why Is Epinephrine Not the Drug of Choice for Cardiogenic Shock
FEATURING
Esther Vorovich
- 2,117 views
- March 10, 2023
- 10
Houston Methodist DeBakey Heart and Vascular Center
Evaluation of New-Onset Heart Failure
FEATURING
Mark Drazner
- 1,474 views
- February 10, 2023
- 10
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation
FEATURING
Michelle Kittleson
- 1,319 views
- February 8, 2022
- 11
Heart Failure 2021: An Update on Therapy
Use of Diuretics in Patients With Volume Overload: What to Do When You See Diuretic Resistance?
FEATURING
Jeffrey Testani
- 644 views
- March 30, 2021
- 11
AHA 2022 Conference Coverage
AHA 2022: Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction
FEATURING
Pieter Martens
- 1,700 views
- November 14, 2022
- 11
Northwestern Medicine: 8th Annual Cardiovascular Update
AF and Heart Failure: What’s the Risk? Is Ablation the Answer?
FEATURING
Jonathan Piccini
- 686 views
- August 14, 2019
- 11
ACHL
Treatment of Iron Deficiency Across the Heart Failure Spectrum
FEATURING
Stormi Gale
- 723 views
- December 7, 2023
- 10
The Texas Heart Institute
Antihyperglycemic Medications for CV Risk Reduction: a Cardiologist's Perspective
FEATURING
Darren K. Mcguire
- 1,230 views
- January 18, 2024
- 10
AHA 2022 Conference Coverage
AHA 2022: GDMT for HFpEF - What Do We and Don't We Know?
FEATURING
Marat Fudim
- 1,412 views
- November 30, 2022
- 11
Canadian Collaborative Research Network
Chronic Kidney Disease: New Treatments to Improve Outcomes
FEATURING
Louise Moist
- 1,527 views
- July 26, 2023
- 10
Clyde Yancy
ACC/AHA/HFSA Update on New Pharmacological Therapy for Heart Failure
- 2,179 views
- October 12, 2016
- 9
The Ludeman Family Center for Women’s Health Research
Taking the "Failure" Out of Heart Failure
FEATURING
Prateeti Khazanie
- 953 views
- January 24, 2022
- 10
Cedars Sinai
SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial
FEATURING
Sanjay Kaul,
Milton Packer
- 1,785 views
- February 7, 2022
- 9
ACC 2022 Conference Coverage
ACC 2022: SGLT2i in Heart Failure - HFrEF, HFpEF, Class Effect?
FEATURING
Stephen Greene
- 1,447 views
- April 12, 2022
- 10
CCM® Therapy
AHA 2020 - Classifying Heart Failure Using NYHA Functional Class Assessment
FEATURING
William Abraham
- 1,283 views
- November 20, 2020
- 10
Boston Scientific
Integrated Heart Failure Patient Management — EP and HF Perspective
- 1,161 views
- September 22, 2021
- 8